Cargando…
COVID-19 Multi-Targeted Drug Repurposing Using Few-Shot Learning
The life-threatening disease COVID-19 has inspired significant efforts to discover novel therapeutic agents through repurposing of existing drugs. Although multi-targeted (polypharmacological) therapies are recognized as the most efficient approach to system diseases such as COVID-19, computational...
Autores principales: | Liu, Yang, Wu, You, Shen, Xiaoke, Xie, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581066/ https://www.ncbi.nlm.nih.gov/pubmed/36303751 http://dx.doi.org/10.3389/fbinf.2021.693177 |
Ejemplares similares
-
Potential COVID-19 papain-like protease PL(pro) inhibitors: repurposing FDA-approved drugs
por: Kouznetsova, Valentina L., et al.
Publicado: (2020) -
Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach
por: Loganathan, Tamizhini, et al.
Publicado: (2020) -
Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets
por: Dobbs Spendlove, Mauri, et al.
Publicado: (2023) -
Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogens
por: Naz, Sadia, et al.
Publicado: (2017) -
Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study
por: Jose, Sandra, et al.
Publicado: (2023)